Hanmi Pharmaceutical credit rating upgraded
Published: 2013-04-18 06:56:00
Updated: 2013-04-18 06:56:00
Hanmi Pharmaceutical, one of the nation’s leading pharmaceutical companies, said Tuesday it has received an upgrade in its credit rating from A (negative) to A0 (stable) from Korea Ratings (KR) and Korea Investors Service.
Citing KR’s recent report, company officials said the latest evaluation...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
